Bartronics India shifts focus to healthcare, plans new subsidiary, name change

Bartronics India Limited (BIL) announced a strategic Memorandum of Understanding (MoU) with Huwel Lifesciences Private Limited, intending to invest up to INR 50,00,00,000 in tranches for a 15% stake in Huwel’s fully diluted equity. This collaboration aims for joint business development, product innovation, and expansion into domestic and global healthcare markets, with BIL having the option to acquire an additional 15% equity within 12 months.

In a board meeting on September 23, 2025, Bartronics India also approved the incorporation of a Wholly Owned Subsidiary in India to enhance operational efficiency and pursue new business opportunities. Additionally, the board proposed initiating steps to change the company’s name, subject to shareholder and regulatory approvals.

BIL will nominate one director to Huwel's board and will have Right of First Refusal on promoter share transfers, along with Tag-Along rights. The proposed investment and collaboration are contingent on due diligence, definitive agreements, and necessary approvals.